Comparison of three types of drugs for cardiovascular and renal benefits in type 2 diabetes mellitus

doi:10.4239/wjd.v16.i11.111280

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

This Article

(43)

(36)

(0)

(1158)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Diabetes. Nov 15, 2025; 16(11): 111280
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.111280

Full Size Figure Download Figure

Figure 3 Results of all-cause mortality. A: Comparison network results for all-cause mortality of three classes of drugs; B: Comparison network results for all-cause mortality of different drugs; C: Forest plot for all-cause mortality of three classes of drugs; D: Forest plot for all-cause mortality of different drugs.

Citation: An XD, Li XQ, Zhang H, Jia QY, Zhang YH, Yang GG. Comparison of three types of drugs for cardiovascular and renal benefits in type 2 diabetes mellitus. World J Diabetes 2025; 16(11): 111280
URL: https://www.wjgnet.com/1948-9358/full/v16/i11/111280.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i11.111280

An XD, Li XQ, Zhang H, Jia QY, Zhang YH, Yang GG. Comparison of three types of drugs for cardiovascular and renal benefits in type 2 diabetes mellitus. World J Diabetes 2025; 16(11): 111280 [PMID: 41278452 DOI: 10.4239/wjd.v16.i11.111280]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.